Sealing The Deal: O'Melveny Nails Historic Buy For China's BGI

Law360, New York (April 30, 2013, 4:22 PM EDT) -- While most Americans were sitting down to a turkey dinner, a group of O'Melveny & Myers LLP attorneys spent their Thanksgiving holiday last November responding to a third-party offer that threatened to derail a historic acquisition by their client, Chinese genome sequencing company BGI-Shenzhen.

BGI had reached an agreement to acquire genome technology firm Complete Genomics Inc. for $117.6 million in September, the first-ever acquisition of a U.S. public company by a Chinese firm. But BGI's U.S. rival, Illumina Inc., made an unsolicited competing offer while...
To view the full article, register now.